Skip to main content
hello world

Closing Bell: Cardiol Therapeutics Inc up on Tuesday (CRDL)

Automated Summaries - The Globe and Mail - Tue Aug 6, 4:02PM CDT

Today, Cardiol Therapeutics Inc shares closed at $2.77 after opening the day at $2.72. prices ranged from a low of $2.66 to a high of $2.80.

Shares raised 1.47% from the previous day's close of $2.73.

Today across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -3.00% at 5186.33, the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08.

Cardiol Therapeutics Inc traded under CRDL on the Toronto Stock Exchange (TSX).

A total of 184,336 shares was traded during the session, with total trades of 732. On average, Cardiol Therapeutics Inc has traded 108,556 shares over the last 5-days and 149,037 year-to-date.

The TSX market on the whole today saw 3,772 price advancers against 1,443 declines and 86 unchanged.

During the prior 52 weeks, CRDL.TO has traded as high as $4.26 (June 12,2024) and low as $0.91 (October 23,2023). Moreover, in the last 52 weeks, Cardiol Therapeutics Inc's shares have boosted 73.13 percent, while they have risen 151.82% since the start of 2024.

Following today's trading, Cardiol Therapeutics Inc has a market capitalization of $189.44 million on a float of 69,391 shares outstanding. Its annual EPS is $-0.47.

Cardiol Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Oakville, CAN.

Cardiol Therapeutics Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..